ATE233252T1 - Substituierte dihydrobenzofurane als pde- hemmstoffe - Google Patents
Substituierte dihydrobenzofurane als pde- hemmstoffeInfo
- Publication number
- ATE233252T1 ATE233252T1 AT97950157T AT97950157T ATE233252T1 AT E233252 T1 ATE233252 T1 AT E233252T1 AT 97950157 T AT97950157 T AT 97950157T AT 97950157 T AT97950157 T AT 97950157T AT E233252 T1 ATE233252 T1 AT E233252T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- pde inhibitors
- dihydrobenzofuranes
- substituted
- substituted dihydrobenzofuranes
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 2
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19647881 | 1996-11-20 | ||
| EP96118743 | 1996-11-22 | ||
| PCT/EP1997/006248 WO1998022453A1 (en) | 1996-11-20 | 1997-11-11 | Substituted dihydrobenzofurans as pde inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE233252T1 true ATE233252T1 (de) | 2003-03-15 |
Family
ID=26031440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97950157T ATE233252T1 (de) | 1996-11-20 | 1997-11-11 | Substituierte dihydrobenzofurane als pde- hemmstoffe |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6054475A (de) |
| EP (1) | EP0941221B1 (de) |
| JP (1) | JP2001505198A (de) |
| AT (1) | ATE233252T1 (de) |
| AU (1) | AU5320698A (de) |
| CY (1) | CY2472B1 (de) |
| DE (1) | DE69719358T2 (de) |
| DK (1) | DK0941221T3 (de) |
| ES (1) | ES2193414T3 (de) |
| PT (1) | PT941221E (de) |
| SI (1) | SI0941221T1 (de) |
| WO (1) | WO1998022453A1 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003525845A (ja) * | 1997-10-28 | 2003-09-02 | ヴィヴァス・インコーポレイテッド | 勃起機能不全の処置のためのホスホジエステラーゼインヒビターの局所投与 |
| CA2715683A1 (en) | 1999-08-21 | 2001-03-01 | Nycomed Gmbh | Synergistic combination |
| CN1440281A (zh) * | 2000-05-03 | 2003-09-03 | 苏坎波公司 | 降眼压药 |
| JP3940290B2 (ja) * | 2000-12-22 | 2007-07-04 | ザ・ヨルダニアン・フアーマシユーテイカル・エム・エフ・ジー・アンド・メデイカル・イクイツプメント・カンパニー・リミテツド | 新規化合物 |
| SE0004780D0 (sv) * | 2000-12-22 | 2000-12-22 | Jordanian Pharmaceutical Mfg & | Novel compunds |
| EP1256578B1 (de) * | 2001-05-11 | 2006-01-11 | Pfizer Products Inc. | Thiazolderivate und ihre Verwendung als cdk-Inhibitoren |
| DE60235198D1 (de) * | 2001-12-20 | 2010-03-11 | Merck Serono Sa Coinsins | Pyrrolidin-derivatie als prostaglandin-modulatoren |
| US6723755B2 (en) | 2002-06-12 | 2004-04-20 | Piotr Chomczynski | Method of treating rosacea |
| US7153824B2 (en) | 2003-04-01 | 2006-12-26 | Applied Research Systems Ars Holding N.V. | Inhibitors of phosphodiesterases in infertility |
| DE10348022A1 (de) * | 2003-10-15 | 2005-05-25 | Imtm Gmbh | Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen |
| US7812057B2 (en) * | 2004-08-25 | 2010-10-12 | Molecular Research Center, Inc. | Cosmetic compositions |
| EP2275095A3 (de) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenese durch modulation des Muscarinrezeptors |
| EP2258358A3 (de) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenese mit Acetylcholinesterasehemmer |
| EP1940389A2 (de) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation von neurogenese durch pde-hemmung |
| AU2006308889A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | GABA receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| JP2009536667A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス，インコーポレイティド | ５ｈｔ受容体介在性の神経新生 |
| EP2382975A3 (de) | 2006-05-09 | 2012-02-29 | Braincells, Inc. | Neurogenese mittels Angiotensin-Modulation |
| AU2007292848A1 (en) | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| WO2013106547A1 (en) | 2012-01-10 | 2013-07-18 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5552438A (en) * | 1992-04-02 | 1996-09-03 | Smithkline Beecham Corporation | Compounds useful for treating allergic and inflammatory diseases |
| DK0772610T3 (da) * | 1994-07-22 | 2001-01-29 | Byk Gulden Lomberg Chem Fab | Dihydrobenzofuraner |
| ATE231501T1 (de) * | 1995-05-18 | 2003-02-15 | Altana Pharma Ag | Phenyldihydrobenzofurane |
| DK0828727T3 (da) * | 1995-05-18 | 2003-04-22 | Altana Pharma Ag | Cyclohexyldihydrobenzofuraner |
-
1997
- 1997-11-11 US US09/284,459 patent/US6054475A/en not_active Expired - Fee Related
- 1997-11-11 AT AT97950157T patent/ATE233252T1/de not_active IP Right Cessation
- 1997-11-11 DK DK97950157T patent/DK0941221T3/da active
- 1997-11-11 ES ES97950157T patent/ES2193414T3/es not_active Expired - Lifetime
- 1997-11-11 AU AU53206/98A patent/AU5320698A/en not_active Abandoned
- 1997-11-11 EP EP97950157A patent/EP0941221B1/de not_active Expired - Lifetime
- 1997-11-11 JP JP52316498A patent/JP2001505198A/ja not_active Ceased
- 1997-11-11 PT PT97950157T patent/PT941221E/pt unknown
- 1997-11-11 SI SI9730523T patent/SI0941221T1/xx unknown
- 1997-11-11 WO PCT/EP1997/006248 patent/WO1998022453A1/en not_active Ceased
- 1997-11-11 DE DE69719358T patent/DE69719358T2/de not_active Expired - Fee Related
-
2004
- 2004-08-11 CY CY0400063A patent/CY2472B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT941221E (pt) | 2003-07-31 |
| DK0941221T3 (da) | 2003-06-10 |
| SI0941221T1 (en) | 2003-10-31 |
| WO1998022453A1 (en) | 1998-05-28 |
| DE69719358D1 (de) | 2003-04-03 |
| JP2001505198A (ja) | 2001-04-17 |
| EP0941221B1 (de) | 2003-02-26 |
| US6054475A (en) | 2000-04-25 |
| AU5320698A (en) | 1998-06-10 |
| ES2193414T3 (es) | 2003-11-01 |
| DE69719358T2 (de) | 2003-12-24 |
| CY2472B1 (en) | 2005-06-03 |
| EP0941221A1 (de) | 1999-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE233252T1 (de) | Substituierte dihydrobenzofurane als pde- hemmstoffe | |
| ATE234300T1 (de) | Benzonaphthyridine als bronchialtherapeutika | |
| ES2083595T3 (es) | Derivados de indol que inhiben la biosintesis de leucotrienos. | |
| DE69831937D1 (de) | Bicyclische protein-farnesyl-transferase inhibitoren | |
| DK1070056T3 (da) | Phthalazinon-PDE III/IV-inhibitorer | |
| DE69618231D1 (de) | TETRAHYDROIMIDAZOPYRIDOINDOLDIONE ALS cGMP SPEZIFISCHE PDE HEMMER | |
| PT920426E (pt) | Novos derivados de tiazole com efeito inibidor de fosfodiesterase | |
| ATE219481T1 (de) | 1,7,7-trimethyl-bicyclo(2.2.1)heptane derivative | |
| MXPA02012470A (es) | Inhibidores de fosfodiesterasa especificos para gmp ciclico. | |
| PT1003724E (pt) | Derivados substituidos com accao antiviral | |
| DE60036558D1 (de) | Phthalazinon-derivate als pde 4 hemmer | |
| ATE293111T1 (de) | Kondensierte pyrazindionderivate als pde inhibitoren | |
| ATE337320T1 (de) | Indolderivate als pde5-inhibitoren | |
| DK0687257T3 (da) | 4-amino-2-(hetero)aryl-butanamider anvendelige som 5HT1A-antagonister |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0941221 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |